risankizumab,tofacitinib,vedolizumab,azacitidine,ustekinumab,ozanimod,upadacitinib,adalimumab,golimumab,infliximab
abbvie,bms,janssen,takeda,pfizer
['ibd']
 inadequate treatment is an adverse event. #aibd2022 
IBD doctor @OHSU | Life and Health Coach | Tweets are my own and are not medical advice